Co-Diagnostics, Inc. Deferred Federal, State and Local, Tax Expense (Benefit)
Co-Diagnostics, Inc. (CODX) reported Deferred Federal, State and Local, Tax Expense (Benefit) of -$2.32 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit · last filed 2025-03-27
- Co-Diagnostics, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2023 was -$2.32M.
- Co-Diagnostics, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2022 was -$4.91M, a 345.53% decline from fiscal 2021.
- Co-Diagnostics, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2021 was $2.00M.
- Co-Diagnostics, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2020 was -$547.22K.
| Period end | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month |
|---|---|
| 2023-12-31 | -$2.32M 10-K · filed 2025-03-27 |
| 2022-12-31 | -$4.91M 10-K · filed 2024-03-14 |
| 2021-12-31 | $2.00M 10-K · filed 2023-03-16 |
| 2020-12-31 | -$547.22K 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |